![](/img/cover-not-exists.png)
PCN67 LOWER ADMINISTRATION COSTS OF BEVACIZUMAB IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY VERSUS CETUXIMAB-VINORELBINE-CISPLATIN THERAPY FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC) FOCUSING ON THREE EUROPEAN HEALTH CARE SYSTEMS
H Rosery, C Castro de, H Bischoff, D Heigener, A Vergnenegre, C Chouaid, S WalzerVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74318-7
File:
PDF, 71 KB
english, 2009